"Monitoring, Immunologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Testing of immune status in the diagnosis and therapy of cancer, immunoproliferative and immunodeficiency disorders, and autoimmune abnormalities. Changes in immune parameters are of special significance before, during and following organ transplantation. Strategies include measurement of tumor antigen and other markers (often by RADIOIMMUNOASSAY), studies of cellular or humoral immunity in cancer etiology, IMMUNOTHERAPY trials, etc.
| Descriptor ID |
D015166
|
| MeSH Number(s) |
E01.370.225.812.505 E01.370.520.505 E05.200.812.505 E05.478.594.550
|
| Concept/Terms |
Monitoring, Immunologic- Monitoring, Immunologic
- Immunologic Monitoring
- Monitoring, Immunological
- Immunological Monitoring
- Immune Monitoring
- Monitoring, Immune
- Immunosurveillance
Radioimmunologic Monitoring- Radioimmunologic Monitoring
- Monitoring, Radioimmunological
- Radioimmunological Monitoring
- Monitoring, Radioimmunologic
|
Below are MeSH descriptors whose meaning is more general than "Monitoring, Immunologic".
Below are MeSH descriptors whose meaning is more specific than "Monitoring, Immunologic".
This graph shows the total number of publications written about "Monitoring, Immunologic" by people in this website by year, and whether "Monitoring, Immunologic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 2 | 4 |
| 2018 | 5 | 5 | 10 |
| 2019 | 1 | 1 | 2 |
| 2020 | 1 | 1 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Monitoring, Immunologic" by people in Profiles.
-
Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients. J Clin Invest. 2021 07 15; 131(14).
-
Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis. Front Immunol. 2021; 12:701752.
-
Parameters of immunoglobulin extraction from dried blood spot cards and immunoassays for detection of antibody response to pathogens including the novel SARS-CoV-2. J Immunol Methods. 2021 05; 492:112996.
-
Anti SARS-CoV-2 antibodies monitoring in a group of residents in a long term care facility during COVID-19 pandemic peak. Diagnosis (Berl). 2020 Nov 18; 7(4):395-400.
-
SARS-CoV-2 antibody-based SURVEILLANCE: New light in the SHADOW. EBioMedicine. 2020 11; 61:103087.
-
The Challenge of Treating Kidney Transplant Recipients Infected with COVID-19: Report of the First Cases in Israel. Isr Med Assoc J. 2020 10; 22(10):602-604.
-
Prolonged Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA in an Obstetric Patient With Antibody Seroconversion. Obstet Gynecol. 2020 10; 136(4):838-841.
-
Clinical benefits of Tocilizumab in COVID-19-related cytokine release syndrome in a patient with end-stage kidney disease on haemodialysis in Australia. Nephrology (Carlton). 2020 Nov; 25(11):845-849.
-
A quadruple blind, randomised controlled trial of gargling agents in reducing intraoral viral load among hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Sep 14; 21(1):785.
-
Immune monitoring facilitates the clinical decision in multifocal COVID-19 of a pancreas-kidney transplant patient. Am J Transplant. 2020 11; 20(11):3210-3215.